Joe Truitt Member of the Audit CommitteeChair of the Compensation Committee Charter Joe Truitt Tom Hamilton Member of the Audit CommitteeMember of the Nominating and Governance Committee Tom Hamilton Larimar Therapeutics to Present at Jefferies Virtual Healthcare Conference Read more about Larimar Therapeutics to Present at Jefferies Virtual Healthcare Conference Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics Read more about Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement Read more about Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement Zafgen Reports Third Quarter 2019 Financial Results Read more about Zafgen Reports Third Quarter 2019 Financial Results Zafgen to Explore Strategic Alternatives Read more about Zafgen to Explore Strategic Alternatives Zafgen Reports Second Quarter 2019 Operating and Financial Results Read more about Zafgen Reports Second Quarter 2019 Operating and Financial Results Zafgen to Present at the Wedbush PacGrow Healthcare Conference Read more about Zafgen to Present at the Wedbush PacGrow Healthcare Conference Zafgen Announces Agreement with U.S. Food and Drug Administration on New Nonclinical Study Design for ZGN-1061 Read more about Zafgen Announces Agreement with U.S. Food and Drug Administration on New Nonclinical Study Design for ZGN-1061 Pagination First page « First Previous page ‹ Previous … Page 4 Page 5 Page 6 Page 7 Current page 8 Page 9 Page 10 Page 11 Page 12 … Next page Next › Last page Last » Subscribe to
Tom Hamilton Member of the Audit CommitteeMember of the Nominating and Governance Committee Tom Hamilton
Larimar Therapeutics to Present at Jefferies Virtual Healthcare Conference Read more about Larimar Therapeutics to Present at Jefferies Virtual Healthcare Conference
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics Read more about Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement Read more about Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement
Zafgen Reports Third Quarter 2019 Financial Results Read more about Zafgen Reports Third Quarter 2019 Financial Results
Zafgen Reports Second Quarter 2019 Operating and Financial Results Read more about Zafgen Reports Second Quarter 2019 Operating and Financial Results
Zafgen to Present at the Wedbush PacGrow Healthcare Conference Read more about Zafgen to Present at the Wedbush PacGrow Healthcare Conference
Zafgen Announces Agreement with U.S. Food and Drug Administration on New Nonclinical Study Design for ZGN-1061 Read more about Zafgen Announces Agreement with U.S. Food and Drug Administration on New Nonclinical Study Design for ZGN-1061